Valuation: Imexpharm Corporation

Market Cap 5,652B 215M 187M 174M 160M 302M 20.5B 307M 2.06B 806M 10.22B 808M 790M 33.71B P/E 2026 *
15.9x
P/E 2027 * 14.7x
Enterprise Value 5,652B 215M 187M 174M 160M 302M 20.5B 307M 2.06B 806M 10.22B 808M 790M 33.71B EV / Sales 2026 *
2.13x
EV / Sales 2027 * 1.96x
Free-Float
6.42%
Yield 2026 *
2.72%
Yield 2027 * 2.72%
1 day+4.56%
1 week+4.86%
Current month+4.56%
1 month-14.05%
3 months-27.76%
6 months-32.04%
Current year-30.10%
1 week 33,950
Extreme 33950
37,000
1 month 32,650
Extreme 32650
43,100
Current year 32,650
Extreme 32650
57,000
1 year 32,650
Extreme 32650
57,000
3 years 23,681.82
Extreme 23681.8182
57,000
5 years 18,831.17
Extreme 18831.1688
57,000
10 years 12,793.53
Extreme 12793.5306
57,000
Manager TitleAgeSince
Chief Executive Officer 74 01/08/2001
Director of Finance/CFO 52 18/01/2024
Chief Operating Officer 47 -
Director TitleAgeSince
Chairman 74 01/01/1984
Director/Board Member 50 28/04/2018
Director/Board Member 53 19/12/2023
Date Insider Type Main position Quantity % Market Cap.
26/9/22 Buy

Chief Executive Officer

140,000 0.2100%
20/7/22 Sell

Chief Executive Officer

100,000 0.1500%
1/4/22 Fiscal year

Chairman

50,000 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+4.56%+4.86%-30.36%+21.46% 206M
-2.93%-6.82%+45.11%+148.43% 1,024B
-1.54%-4.99%+47.73%+48.08% 618B
-2.19%-4.33%+24.65%+64.91% 443B
+0.68%-1.14%+39.61%+33.36% 349B
-1.66%-3.13%+31.63%+39.79% 297B
-8.96%-10.77%+3.27%+5.50% 264B
-1.37%-7.41%-3.42%-43.67% 209B
-2.03%+0.81%+25.62%+64.41% 208B
-0.66%-0.48%+13.44%+71.98% 162B
Average -1.43%-0.72%+19.73%+45.43% 357.4B
Weighted average by Cap. -2.09%-2.17%+32.88%+70.34%

Financials

2026 *2027 *
Net sales 2,659B 101M 87.92M 82.08M 75.35M 142M 9.64B 145M 968M 379M 4.81B 380M 372M 15.86B 2,881B 110M 95.26M 88.93M 81.64M 154M 10.45B 157M 1.05B 411M 5.21B 412M 403M 17.18B
Net income 394B 14.99M 13.03M 12.16M 11.16M 21.05M 1.43B 21.42M 143M 56.17M 712M 56.3M 55.05M 2.35B 428B 16.28M 14.15M 13.21M 12.13M 22.87M 1.55B 23.27M 156M 61.01M 774M 61.16M 59.81M 2.55B
Net Debt - -
Logo Imexpharm Corporation
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Employees
1,438
Date Price Change Volume
03/08/26 36,700.00 +4.56% 6,551
31/07/26 ₫35,100.00 -2.50% 14,190
30/07/26 ₫36,000.00 +0.84% 8,294
29/07/26 ₫35,700.00 +2.00% 7,894
28/07/26 ₫35,000.00 0.00% 8,610
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
36,700.00VND
Average target price
56,000.00VND
Spread / Average Target
+52.59%

Annual profits - Rate of surprise